# Fate Therapeutics, Inc. (FATE): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/fate for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe. A significant portion of its development pipeline concentrates on NK- and T-cell immuno-oncology programs. Key candidates include FT516, which targets acute myeloid leukemia (AML), B-cell lymphoma, and advanced solid tumors; FT596 for B-cell lymphoma and chronic lymphocytic leukemia; FT538, addressing AML and multiple myeloma; FT576, also focused on mult...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $2.11 USD |
| Market Cap | $245.9M |
| P/E (TTM) | — |
| EPS (TTM) | −$1.05 |
| 52-Week Range | $0.95 – $3.23 |
| Dividend Yield (TTM) | — |

## Dividend

FATE has no dividend payment history in our records.

## Frequently Asked Questions

### What does Fate Therapeutics, Inc. do?

Fate Therapeutics, Inc. (FATE) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is FATE's market cap?

Fate Therapeutics, Inc. (FATE) has a market capitalization of approximately $245.9 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does FATE pay a dividend?

No, Fate Therapeutics, Inc. (FATE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is FATE profitable?

Fate Therapeutics, Inc. (FATE) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has FATE ever paid a dividend?

No. Dividend Data's records show no dividend payments from Fate Therapeutics, Inc. (FATE). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/fate
- Dividend history & safety: https://www.dividenddata.com/stocks/fate/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/fate/earnings
- Financial statements: https://www.dividenddata.com/stocks/fate/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/fate/valuation
- Peer comparison: https://www.dividenddata.com/stocks/fate/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.